Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Mixing Time Optimization – V 2.0

Posted on By

Elixir Department: SOP for Mixing Time Optimization – V 2.0

Standard Operating Procedure for Mixing Time Optimization in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/086/2025
Supersedes SOP/ELX/086/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define a validated procedure for optimizing the mixing time of elixir formulations to ensure uniformity, product quality, and process efficiency during batch manufacturing.

2. Scope

This SOP applies to all mixing operations involving active ingredients, excipients, solvents, and additives during the batch processing of elixirs in the Elixir Department.

3. Responsibilities

  • Production Operator:
    • Perform mixing as per batch instructions and monitor time, speed, and parameters.
  • Production Supervisor:
    • Ensure that the optimized mixing time is followed and recorded accurately.
    • Verify homogeneity tests when applicable.
  • QA Officer:
    • Approve optimized time based on validation data and verify adherence during batch execution.
See also  Elixir Department: SOP for Electronic Batch Record Systems - V 2.0

4. Accountability

The Head of Production is accountable for implementation and periodic review of mixing time optimization protocols to ensure consistent batch performance.

5. Procedure

5.1 Basis for Optimization

  1. Determine mixing time through development studies
using:
  • Visual inspection
  • pH uniformity
  • Content uniformity sampling
  • Viscosity measurement (if applicable)
  • Final optimized mixing time shall be recorded in the Master Formula Record (MFR).
  • 5.2 Mixing Time Execution

    1. Set the mixing equipment to the validated speed (RPM) and time duration.
    2. Start timer immediately when mixing begins and record start time in the BMR.
    3. Do not interrupt mixing unless an alarm or deviation occurs.

    5.3 Monitoring During Mixing

    1. Observe vortex formation, fluid movement, and any signs of foaming or sedimentation.
    2. Record RPM, batch volume, and equipment ID in the Mixing Log (Annexure-1).
    3. Perform in-process sampling if required after mixing completion to confirm homogeneity.

    5.4 Adjustment of Mixing Time

    1. If any parameter deviates (e.g., incomplete dissolution), extend mixing time by 5–15 minutes after consultation with QA.
    2. Document justification, revised time, and responsible personnel in the Deviation Record.

    5.5 Documentation

    1. Record start and end times, RPM, equipment used, and observations in the Mixing Log.
    2. Attach log to the BMR for QA review.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • BMR: Batch Manufacturing Record
    • MFR: Master Formula Record
    • RPM: Revolutions Per Minute

    7. Documents

    1. Mixing Log (Annexure-1)
    2. Deviation Record (if applicable)
    3. Batch Manufacturing Record (BMR)

    8. References

    • 21 CFR Part 211.100 – Written Procedures; Deviations
    • ICH Q8 – Pharmaceutical Development
    • WHO TRS 986 – GMP for Pharmaceuticals

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Mixing Log

    Date Batch No. Start Time End Time RPM Equipment ID Operator Remarks
    11/04/2025 ELX-1025 09:30 AM 10:00 AM 250 MX-04 Rajesh Kumar Uniform mix achieved

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Added optimization methods and adjustment protocol Process Improvement QA Head
    See also  Elixir Department: SOP for Control of Alcohol Evaporation Loss - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: Comparison of FTIR Spectra in AMD – V 2.0
    Next Post: Sterile Injectable Manufacturing: SOP for Intramuscular Injection Batch Manufacturing – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version